The synergistic effect of CDKN2B-AS1 and SPC25 on triple-negative breast cancer

BACKGROUND: Accumulating evidence suggests that long non-coding ribonucleic acid (RNA) cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1) and messenger RNA (mRNA) spindle component 25 (SPC25) contribute to tumorigenesis and progression in various cancers. However, the synergistic effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Na, Chen, Keyan, Fan, Hua, Jin, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372695/
https://www.ncbi.nlm.nih.gov/pubmed/35965791
http://dx.doi.org/10.21037/atm-22-2900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372695/
https://www.ncbi.nlm.nih.gov/pubmed/35965791
http://dx.doi.org/10.21037/atm-22-2900

Ejemplares similares